Comparative study of clinical presentation and hematological indices in hospitalized sickle cell patients with severe Plasmodium falciparum malaria

被引:10
|
作者
Purohit, Prasanta [1 ,2 ]
Mohanty, Pradeep K. [3 ]
Patel, Siris [1 ,2 ]
Das, Padmalaya [4 ]
Panigrahi, Jogeswar [5 ,6 ]
Das, Kishalaya [1 ,2 ]
机构
[1] Veer Surendra Sai Inst Med Sci & Res VIMSAR, Sickle Cell Clin, Sickle Cell Inst Bldg,PO Burla, Sambalpur 768017, Odisha, India
[2] Veer Surendra Sai Inst Med Sci & Res VIMSAR, Mol Biol Lab, Sickle Cell Inst Bldg,PO Burla, Sambalpur, Odisha, India
[3] Veer Surendra Sai Inst Med Sci & Res VIMSAR, Dept Med, Sambalpur, Odisha, India
[4] Asian Inst Publ Hlth, Dept Infect Dis, Bhubaneswar, Odisha, India
[5] Sambalpur Univ, Sch Life Sci, Burla, Odisha, India
[6] Cent Univ Rajasthan, Sch Life Sci, Dept Biotechnol, Kishangarh, Rajasthan, India
关键词
Plasmodium falciparum; Severe malaria; Sickle cell gene; Anemia; Mortality; IMMUNE-RESPONSES; MORTALITY; ANEMIA; MANIFESTATIONS; ERYTHROCYTES; MORBIDITY; MICRORNAS; ANTIGENS; CHILDREN; DISEASE;
D O I
10.1016/j.jiph.2017.08.013
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Sickle-cell-gene has a high frequency in malaria endemic regions. In India, though the prevalence of both sickle-cell-gene and malaria are high, no study has been carried out. This study aims to find out the possible differences in hematological and clinical parameters in severe falciparum malaria with respect to sickle cell genotypes. Methods: Five hundred fourteen adults with severe falciparum malaria hospitalized in Department of Medicine, Veer Surendra Sai Institute of Medical Sciences and Research, Burla, between August, 2010 to December, 2014 were included and categorized on the basis of sickle cell genotypes. The hematological parameters were compared by one-way-analysis-of-variance and incidence of sub-phenotypes of severe malaria was compared by chi(2) test across the groups. Results: Patients with sickle cell anemia (HbSS) and severe falciparum malaria had lower hemoglobin level compared to patients with normal p-globin genotype (HbAA) and sickle cell trait (HbAS). Most of the hematological parameters were homogeneous in patients with HbAA and HbAS and different from patients with HbSS. Incidence of acute renal failure was low (chi(2), 9.91; p, 0.002) and jaundice was high (chi(2), 5.20; p, 0.022) in patients with HbSS. No clinical difference was observed in patients with HbAA and HbAS. The mortality was low (chi(2), 4.33; p, 0.037) and high (chi(2),10.48; p, 0.001) in patients with HbAS and HbSS respectively compared to patients with HbAA. Conclusion: Though sickle-cell-gene protects against falciparum infections, the hematological parameters and sub-phenotypes of severe malaria remain unchanged when the infection progresses to a severe form in patients with HbAA and HbAS. Presence of hemolytic anemia in patients with HbSS shows diverse hematological and clinical phenotypes as compared to others. High mortality in patients with HbSS emphasizes the need for a better preventive approach to save valuable lives. (C) 2017 The Authors. Published by Elsevier Limited on behalf of King Saud Bin Abdulaziz University for Health Sciences.
引用
收藏
页码:321 / 325
页数:5
相关论文
共 50 条
  • [21] Sickle cell anaemia and severe Plasmodium falciparum malaria: a secondary analysis of the Transfusion and Treatment of African Children Trial (TRACT)
    Uyoga, Sophie
    Olupot-Olupot, Peter
    Connon, Roisin
    Kiguli, Sarah
    Opoka, Robert O.
    Alaroker, Florence
    Muhindo, Rita
    Macharia, Alexander W.
    Dondorp, Arjen M.
    Gibb, Diana M.
    Walker, A. Sarah
    George, Elizabeth C.
    Maitland, Kathryn
    Williams, Thomas N.
    LANCET CHILD & ADOLESCENT HEALTH, 2022, 6 (09): : 606 - 613
  • [22] Characterization of severe Plasmodium falciparum malaria patients in an Angolan general ICU
    Esmael Tomás
    E Filipe
    E Viegas
    A Sá
    F Silva
    L Antunes
    E Lafuente
    Malaria Journal, 9 (Suppl 2)
  • [23] Age as a risk factor for severe Plasmodium falciparum malaria in nonimmune patients
    Schwartz, E
    Sadetzki, S
    Murad, H
    Raveh, D
    CLINICAL INFECTIOUS DISEASES, 2001, 33 (10) : 1774 - 1777
  • [24] SOLUBLE ANTIGENS IN BLOOD OF AFRICAN PATIENTS WITH SEVERE PLASMODIUM FALCIPARUM MALARIA
    MCGREGOR, IA
    TURNER, MW
    WILLIAMS, K
    HALL, P
    LANCET, 1968, 1 (7548): : 881 - &
  • [25] Delayed clinical presentation of Plasmodium falciparum malaria after leaving an endemic area: a tale of two patients
    Pennington, Kaylin
    Ives, Samuel T.
    Frosch, Anne E. P.
    Shaughnessy, Megan K.
    JOURNAL OF TRAVEL MEDICINE, 2020, 27 (06)
  • [26] MEFLOQUINE DISPOSITION IN NORMALS AND IN PATIENTS WITH SEVERE PLASMODIUM-FALCIPARUM MALARIA
    JUMA, FD
    OGETO, JO
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1989, 14 (01) : 15 - 17
  • [27] Mast cell activation in the skin of Plasmodium falciparum malaria patients
    Panop Wilainam
    Rungrat Nintasen
    Parnpen Viriyavejakul
    Malaria Journal, 14
  • [28] Mast cell activation in the skin of Plasmodium falciparum malaria patients
    Wilainam, Panop
    Nintasen, Rungrat
    Viriyavejakul, Parnpen
    MALARIA JOURNAL, 2015, 14
  • [29] Analysis of clinical presentation, hematological factors, self-reported bed net usage, and malaria burden in sickle cell disease patients
    Harp, Keri Oxendine
    Botchway, Felix
    Dei-Adomakoh, Yvonne
    Wilson, Michael D.
    Mubasher, Mohamed
    Adjei, Andrew A.
    Thompson, Winston E.
    Stiles, Jonathan K.
    Driss, Adel
    ECLINICALMEDICINE, 2021, 39
  • [30] Clinical and haematologic indices in Plasmodium falciparum-infected children with the sickle-cell haemoglobin gene in Western Kenya
    Otieno, Richard O.
    Ong'echa, John Michael
    Ouma, Collins
    Were, Tom
    Keller, Chris
    Waindi, E. N.
    Vulule, John M.
    Perkins, Douglas J.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2005, 73 (06): : 350 - 350